DNB Markets, Back Bay Life Science Advisors and KD Pharma Transaction UpdatesDNB//Back BayOctober 10, 2024M&A, Transactions, DNB//Back Bay
Key Considerations for Healthcare Companies Listing on a US Exchange (Podcast) PodcastDNB//Back BayMay 23, 2024IPO, Healthcare, M&A
The Transactional Landscape Of ADCs: A Payday for Payloads BlogBack Bay Life Science AdvisorsMarch 2, 2023Capital, Biotech, M&A, Oncology, Transactions, Deal Landscape, Small Molecule Therapeutics
Versantis to be acquired by GENFIT Press Release, Client NewsBack Bay Life Science AdvisorsSeptember 19, 2022Transactions, Diligence, Biotech, M&A
With Biotech Public Valuations Down, Look to Alternative Strategies to Enhance Company Value BlogBack Bay Life Science AdvisorsJanuary 31, 2022Valuation, Investment, M&A, Investment Banking
Back Bay in Wall Street Journal, Pro Venture Capital: Medical-Device IPOs, Acquisitions Jumped in 2021 Media CoverageBack Bay Life Science AdvisorsJanuary 15, 2022Investing, Medical Device, IPOs, M&A
Back Bay Served as Financial Advisor in Acquisition of Novellus Therapeutics by Brooklyn ImmunoTherapeutics [Back Bay Transaction] Back Bay Transaction NewsInvestment Banking TeamJuly 20, 2021M&A, Investment Banking, Biopharma, Oncology, Cell Therapy
Investment Banking Spotlight: Jazz Pharmaceuticals to Acquire GW Pharmaceuticals Back Bay Deal TeamInvestment Banking TeamFebruary 23, 2021Biotech, M&A, Drug Development, Cannabidiol, Blockbuster, Life Sciences
